About the AG

  • Subscribe to the AG's RSS Feed
  • Join the AG's FaceBook
  • Follow the AG on Twitter
  • View the AG's YouTube Channel

Attorney General Kamala D. Harris, 48 State Attorneys General Announce a $71 Million Consumer Settlement with Amgen Over Biologic Medications

Tuesday, August 18, 2015
Contact: (415) 703-5837, agpressoffice@doj.ca.gov

LOS ANGELES -- California Attorney General Kamala D. Harris today announced that California and 47 other states and the District of Columbia have reached a $71 million settlement with pharmaceutical company Amgen Inc. to resolve allegations that Amgen unlawfully promoted biologic medications Aranesp and Enbrel. California will receive $4.6 million from the settlement.

Aranesp is used to treat certain types of anemia by stimulating bone marrow to produce red blood cells.  Enbrel is used to treat a number of conditions, including plaque psoriasis. 

“Amgen’s false marketing denied consumers the ability to make educated decisions about their healthcare,” said Attorney General Harris. “This settlement will hold the company accountable for its deceptive marketing and prevent it from using misleading practices in the future.”

In documents filed today, Attorney General Harris and the other attorneys general allege that Amgen violated state consumer protection laws by: (1) promoting Aranesp for dosing frequencies longer than the FDA approved label without competent and reliable scientific evidence to substantiate the extended dosing frequencies; (2) promoting Aranesp for anemia caused by cancer without having FDA approval or competent and reliable scientific evidence to support it; and (3) promoting Enbrel for mild plaque psoriasis even though Enbrel is only approved by the FDA to treat chronic moderate to severe plaque psoriasis.

The consent judgment requires Amgen to reform its marketing and promotional practices.  For example, under the terms of the consent judgment, Amgen may not make false, deceptive, or misleading written or oral claims in promoting Enbrel or any drug in the same class as Aranesp.

The other states participating in the settlement are Alabama, Alaska, Arizona, Arkansas, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, as well as the District of Columbia. 

# # #

Press Office Contacts

Email: agpressoffice@doj.ca.gov

Phone Number: (415) 703-5837

Subscriptions

Megan's Law

California Registered Sex Offender Database

Search Now

Site Navigation

Translate Website

  • Google™ Translation Disclaimer

This Google™ translation feature is provided for informational purposes only.

The Office of the Attorney General is unable to guarantee the accuracy of this translation and is therefore not liable for any inaccurate information resulting from the translation application tool.

Please consult with a translator for accuracy if you are relying on the translation or are using this site for official business.

If you have any questions please contact:Bilingual Services Program at (916) 324-5482

A copy of this disclaimer can also be found on our Disclaimer page.

Select a Language Below / Seleccione el Idioma Abajo

Close this box or use the [ X ]